You are here

  • Home
  • Archive
  • Volume 90, Issue 3
  • Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme

Citation Tools

Article menu

Download PDFPDF

Multiple sclerosis
Research paper
Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Palace J, Duddy M, Lawton M, et al
Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme
Journal of Neurology, Neurosurgery & Psychiatry 2019;90:251-260.